Aerie Pharma (AERI) Misses Q4 EPS by 5c

Aerie Pharma (NASDAQ: AERI) reported Q4 EPS of ($0.72), $0.05 worse than the analyst estimate of ($0.67).

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Genesco (GCO) Tops Q2 EPS by 54c ; Offers Guidance
• PVH Corp. (PVH) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY27 EPS Guidance
• Five Below raises full-year outlook after strong second-quarter sales growth